Verified Nov 2026
Batteries & E-Mobility
·

Addlestone, England
·
Since 2005
Astellas Pharma Europe is a global life sciences company headquartered in Addlestone, England, established in 2005 through the merger of Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical. With 10,000–50,000 employees and revenue exceeding $10 billion, the company develops specialty medicines across oncology, ophthalmology, urology, immunology, and women's health. It operates in over 70 countries and has expanded its Irish manufacturing capacity in recent years.
Astellas Pharma Europe at a glance
Revenue
$10B+
Est. band
Employees
10,000-50,000
Founded
2005
Headquarters
Addlestone, England
Certifications
ISO 14001 · ISO 45001 · ISO 9001
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
STABILITY SIGNALS
Established & active
21 years in operation (founded 2005).
Holds ISO 14001, ISO 45001, ISO 9001 certification(s) per public sources.
Overview
Astellas Pharma Europe is a global life sciences company headquartered in Addlestone, England, established in 2005 through the merger of Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical. With 10,000–50,000 employees and revenue exceeding $10 billion, the company develops specialty medicines across oncology, ophthalmology, urology, immunology, and women's health. It operates in over 70 countries and has expanded its Irish manufacturing capacity in recent years.
At a glance
Attribute | Detail |
|---|---|
Founded | 2005 |
Headquarters | Addlestone, England |
Employees | 10,000-50,000 |
Revenue | $10B+ (estimated) |
Primary capability | Batteries & E-Mobility |
Certifications | ISO 14001 · ISO 45001 · ISO 9001 |
What Astellas Pharma Europe makes
The company holds ISO 9001, ISO 14001, and ISO 45001 certifications and invests 14.7 percent of sales revenue into research and development across specialty therapeutic areas.
Certifications
Astellas Pharma Europe is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 14001 — contractpharma.com
ISO 45001 — chemicalbrowser.com
ISO 9001 — chemicalbrowser.com
Latest developments
2026-09-14 — Astellas Expands Investment in Ireland | IDA Ireland (idaireland.com)
2026-09-14 — Pharma giant Astellas announces expansion of Tralee manufacturing facility | RadioKerry.ie (radiokerry.ie)
2026-09-04 — Exp. CONTR 2026 0000295757 · huj_cbam_(1º prorroga)_am 8/2025_astellas pharma, s.a._suministro… | El Vínculo (el-vinculo.com)
2026-08-19 — Astellas applies for planning for new staff canteen at major Tralee facility | RadioKerry.ie (radiokerry.ie)
2026-02-13 — Astellas’ expansion recognised as being among Europe’s top projects | RadioKerry.ie (radiokerry.ie)
2025-09-04 — Astellas comes to the Bridge | EurobuildCEE (eurobuildcee.com)
Facilities
Astellas Pharma Europe is headquartered in Addlestone, England. Public sources also reference these locations:
Japan — eurobuildcee.com
Company details
Astellas operates as a subsidiary of its Japanese parent entity and has reached over 172 million patients since inception through collaborative partnerships in global healthcare. Astellas Pharma Europe was founded in 2005, has an estimated 10,000-50,000 employees, and is headquartered in Addlestone, England. On the LightSource stability read it is rated "Established & active": 21 years in operation (founded 2005). Holds ISO 14001, ISO 45001, ISO 9001 certification(s) per public sources.
Frequently asked questions
What does Astellas Pharma Europe make?
Astellas Pharma Europe is a global life sciences company headquartered in Addlestone, England, established in 2005 through the merger of Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical. With 10,000–50,000 employees and revenue exceeding $10 billion, the company develops specialty medicines across oncology, ophthalmology, urology, immunology, and women's health. It operates in over 70 countries and has expanded its Irish manufacturing capacity in recent years.
Where is Astellas Pharma Europe headquartered?
Astellas Pharma Europe is headquartered in Addlestone, England.
When was Astellas Pharma Europe founded?
Astellas Pharma Europe was founded in 2005.
How big is Astellas Pharma Europe?
Astellas Pharma Europe has an estimated 10,000-50,000 employees, with revenue in the $10B+ range (estimated).
What certifications does Astellas Pharma Europe hold?
Astellas Pharma Europe lists ISO 14001 · ISO 45001 · ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Phone
'+44 80 0727 7003
Certification
ISO 14001 · ISO 45001 · ISO 9001
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
